Financing ·
AbbVie Inc. has entered into an agreement to issue approximately $7.95 billion in various senior notes, including both…
ABBVAbbVie Inc.
AbbVie Inc. has entered into an agreement to issue approximately $7.95 billion in various senior notes, including both floating and fixed-rate tranches. The company intends to use the net proceeds to repay $2.0 billion of its 364-day delayed draw term loan facility maturing in May 2026 and for general corporate purposes. This significant issuance allows AbbVie to proactively manage its upcoming debt maturities and optimize its long-term capital structure.